IBDEI0NF ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23610,1,3,0)
 ;;=3^NPH w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,23610,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,23610,2)
 ;;=^5004174^F02.80
 ;;^UTILITY(U,$J,358.3,23611,0)
 ;;=G30.8^^89^1066^5
 ;;^UTILITY(U,$J,358.3,23611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23611,1,3,0)
 ;;=3^Alzheimer's Diseases NEC
 ;;^UTILITY(U,$J,358.3,23611,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,23611,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,23612,0)
 ;;=G31.09^^89^1066^16
 ;;^UTILITY(U,$J,358.3,23612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23612,1,3,0)
 ;;=3^Frontotemporal Dementia NEC
 ;;^UTILITY(U,$J,358.3,23612,1,4,0)
 ;;=4^G31.09
 ;;^UTILITY(U,$J,358.3,23612,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,23613,0)
 ;;=G20.^^89^1066^24
 ;;^UTILITY(U,$J,358.3,23613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23613,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,23613,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,23613,2)
 ;;=^5003770^F02.81
 ;;^UTILITY(U,$J,358.3,23614,0)
 ;;=G20.^^89^1066^25
 ;;^UTILITY(U,$J,358.3,23614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23614,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,23614,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,23614,2)
 ;;=^5003770^F02.80
 ;;^UTILITY(U,$J,358.3,23615,0)
 ;;=G31.01^^89^1066^26
 ;;^UTILITY(U,$J,358.3,23615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23615,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,23615,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,23615,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,23616,0)
 ;;=G23.1^^89^1066^28
 ;;^UTILITY(U,$J,358.3,23616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23616,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia
 ;;^UTILITY(U,$J,358.3,23616,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,23616,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,23617,0)
 ;;=Z79.2^^89^1067^1
 ;;^UTILITY(U,$J,358.3,23617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23617,1,3,0)
 ;;=3^Antibiotics
 ;;^UTILITY(U,$J,358.3,23617,1,4,0)
 ;;=4^Z79.2
 ;;^UTILITY(U,$J,358.3,23617,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,23618,0)
 ;;=Z79.01^^89^1067^2
 ;;^UTILITY(U,$J,358.3,23618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23618,1,3,0)
 ;;=3^Anticoagulants
 ;;^UTILITY(U,$J,358.3,23618,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,23618,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,23619,0)
 ;;=Z79.02^^89^1067^3
 ;;^UTILITY(U,$J,358.3,23619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23619,1,3,0)
 ;;=3^Antiplatelets/Antithrombotics
 ;;^UTILITY(U,$J,358.3,23619,1,4,0)
 ;;=4^Z79.02
 ;;^UTILITY(U,$J,358.3,23619,2)
 ;;=^5063331
 ;;^UTILITY(U,$J,358.3,23620,0)
 ;;=Z79.82^^89^1067^4
 ;;^UTILITY(U,$J,358.3,23620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23620,1,3,0)
 ;;=3^Aspirin
 ;;^UTILITY(U,$J,358.3,23620,1,4,0)
 ;;=4^Z79.82
 ;;^UTILITY(U,$J,358.3,23620,2)
 ;;=^5063340
 ;;^UTILITY(U,$J,358.3,23621,0)
 ;;=Z79.4^^89^1067^5
 ;;^UTILITY(U,$J,358.3,23621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23621,1,3,0)
 ;;=3^Insulin
 ;;^UTILITY(U,$J,358.3,23621,1,4,0)
 ;;=4^Z79.4
 ;;^UTILITY(U,$J,358.3,23621,2)
 ;;=^5063334
 ;;^UTILITY(U,$J,358.3,23622,0)
 ;;=Z79.1^^89^1067^7
 ;;^UTILITY(U,$J,358.3,23622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23622,1,3,0)
 ;;=3^NSAID
 ;;^UTILITY(U,$J,358.3,23622,1,4,0)
 ;;=4^Z79.1
 ;;^UTILITY(U,$J,358.3,23622,2)
 ;;=^5063332
 ;;^UTILITY(U,$J,358.3,23623,0)
 ;;=Z79.891^^89^1067^8
 ;;^UTILITY(U,$J,358.3,23623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23623,1,3,0)
 ;;=3^Opiate Analgesic
 ;;^UTILITY(U,$J,358.3,23623,1,4,0)
 ;;=4^Z79.891
 ;;^UTILITY(U,$J,358.3,23623,2)
 ;;=^5063342
 ;;^UTILITY(U,$J,358.3,23624,0)
 ;;=Z79.51^^89^1067^9
 ;;^UTILITY(U,$J,358.3,23624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23624,1,3,0)
 ;;=3^Steroids-Inhaled
 ;;^UTILITY(U,$J,358.3,23624,1,4,0)
 ;;=4^Z79.51
 ;;^UTILITY(U,$J,358.3,23624,2)
 ;;=^5063335
 ;;^UTILITY(U,$J,358.3,23625,0)
 ;;=Z79.52^^89^1067^10
 ;;^UTILITY(U,$J,358.3,23625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23625,1,3,0)
 ;;=3^Steroids-Systemic
 ;;^UTILITY(U,$J,358.3,23625,1,4,0)
 ;;=4^Z79.52
 ;;^UTILITY(U,$J,358.3,23625,2)
 ;;=^5063336
 ;;^UTILITY(U,$J,358.3,23626,0)
 ;;=Z79.899^^89^1067^6
 ;;^UTILITY(U,$J,358.3,23626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23626,1,3,0)
 ;;=3^Long Term Current Drug Therapy NEC
 ;;^UTILITY(U,$J,358.3,23626,1,4,0)
 ;;=4^Z79.899
 ;;^UTILITY(U,$J,358.3,23626,2)
 ;;=^5063343
 ;;^UTILITY(U,$J,358.3,23627,0)
 ;;=96101^^90^1068^43^^^^1
 ;;^UTILITY(U,$J,358.3,23627,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23627,1,2,0)
 ;;=2^96101
 ;;^UTILITY(U,$J,358.3,23627,1,3,0)
 ;;=3^PSYCH TST,PSYCH/PHYS,PER HR W/ INTERP & RPT
 ;;^UTILITY(U,$J,358.3,23628,0)
 ;;=96102^^90^1068^42^^^^1
 ;;^UTILITY(U,$J,358.3,23628,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23628,1,2,0)
 ;;=2^96102
 ;;^UTILITY(U,$J,358.3,23628,1,3,0)
 ;;=3^PSYCH TST,ADMIN BY TECH,PER HR W/ INTERP & RPT
 ;;^UTILITY(U,$J,358.3,23629,0)
 ;;=96118^^90^1068^36^^^^1
 ;;^UTILITY(U,$J,358.3,23629,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23629,1,2,0)
 ;;=2^96118
 ;;^UTILITY(U,$J,358.3,23629,1,3,0)
 ;;=3^NEUROPSYCH TST,PSYCH/PHYS,PER HR W/ INTERP & RPT
 ;;^UTILITY(U,$J,358.3,23630,0)
 ;;=96119^^90^1068^35^^^^1
 ;;^UTILITY(U,$J,358.3,23630,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23630,1,2,0)
 ;;=2^96119
 ;;^UTILITY(U,$J,358.3,23630,1,3,0)
 ;;=3^NEUROPSYCH TST,ADMIN BY TECH,PER HR W/ INTERP & RPT
 ;;^UTILITY(U,$J,358.3,23631,0)
 ;;=96120^^90^1068^34^^^^1
 ;;^UTILITY(U,$J,358.3,23631,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23631,1,2,0)
 ;;=2^96120
 ;;^UTILITY(U,$J,358.3,23631,1,3,0)
 ;;=3^NEUROPSYCH TST,ADMIN BY COMPUTER W/ INTERP & RPT
 ;;^UTILITY(U,$J,358.3,23632,0)
 ;;=96125^^90^1068^55^^^^1
 ;;^UTILITY(U,$J,358.3,23632,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23632,1,2,0)
 ;;=2^96125
 ;;^UTILITY(U,$J,358.3,23632,1,3,0)
 ;;=3^STANDARDIZED COGNITIVE PERFORM TST,PER HR W/ INTERP & RPT
 ;;^UTILITY(U,$J,358.3,23633,0)
 ;;=90882^^90^1068^18^^^^1
 ;;^UTILITY(U,$J,358.3,23633,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23633,1,2,0)
 ;;=2^90882
 ;;^UTILITY(U,$J,358.3,23633,1,3,0)
 ;;=3^ENVIRONM INTERV FOR MED MGMT W/ EMPLOYER/AGENCY/INSTITUTION
 ;;^UTILITY(U,$J,358.3,23634,0)
 ;;=90887^^90^1068^13^^^^1
 ;;^UTILITY(U,$J,358.3,23634,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23634,1,2,0)
 ;;=2^90887
 ;;^UTILITY(U,$J,358.3,23634,1,3,0)
 ;;=3^CONSULTATION W/ FAMILY FOR INTERP/EXPLAN EXAM/TEST RESULTS
 ;;^UTILITY(U,$J,358.3,23635,0)
 ;;=96105^^90^1068^7^^^^1
 ;;^UTILITY(U,$J,358.3,23635,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23635,1,2,0)
 ;;=2^96105
 ;;^UTILITY(U,$J,358.3,23635,1,3,0)
 ;;=3^ASSESSMENT OF APHASIA W/ INTERP & RPT,PER HR BY PHD/PHYS
 ;;^UTILITY(U,$J,358.3,23636,0)
 ;;=96103^^90^1068^41^^^^1
 ;;^UTILITY(U,$J,358.3,23636,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23636,1,2,0)
 ;;=2^96103
 ;;^UTILITY(U,$J,358.3,23636,1,3,0)
 ;;=3^PSYCH TST ADMIN BY COMPUTER W/ INTER & RPT
 ;;^UTILITY(U,$J,358.3,23637,0)
 ;;=96110^^90^1068^16^^^^1
 ;;^UTILITY(U,$J,358.3,23637,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23637,1,2,0)
 ;;=2^96110
 ;;^UTILITY(U,$J,358.3,23637,1,3,0)
 ;;=3^DEVELOPMENTAL SCREEN w/ SCORE & DOCUM,BY PHD/PHYS
 ;;^UTILITY(U,$J,358.3,23638,0)
 ;;=96111^^90^1068^17^^^^1
 ;;^UTILITY(U,$J,358.3,23638,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23638,1,2,0)
 ;;=2^96111
 ;;^UTILITY(U,$J,358.3,23638,1,3,0)
 ;;=3^DEVELOPMENTAL TEST W/ INTERP & RPT
 ;;^UTILITY(U,$J,358.3,23639,0)
 ;;=96116^^90^1068^33^^^^1
 ;;^UTILITY(U,$J,358.3,23639,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23639,1,2,0)
 ;;=2^96116
 ;;^UTILITY(U,$J,358.3,23639,1,3,0)
 ;;=3^NEUROBEHAV STATUS EXAM,PSYCH/PHYS PER HR
